Antenatal Indomethacin Tocolysis Is Associated With an Increased Need for Surgical Ligation of Patent Ductus Arteriosus in Preterm Infants

Journal of Obstetrics and Gynaecology Canada

Volumn 32, Issue 5, 2010, Pages 435-442

  Soraisham, Amuchou S ^a,b   Dalgleish, Stacey ^b   Singhal, Nalini ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

Author keywords

Indomethacin; Patent ductus arteriosus; Prematurity; Tocolysis

Indexed keywords

INDOMETACIN; UTERUS SPASMOLYTIC AGENT;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; PATENT DUCTUS ARTERIOSUS; PREMATURE LABOR; PREMATURITY; PRENATAL DRUG EXPOSURE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ADULT; CASE CONTROL STUDY; LIGATION; NEWBORN;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; LIGATION; MALE; PREMATURE BIRTH; RETROSPECTIVE STUDIES; TOCOLYTIC AGENTS;

EID: 77954940500     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34496-6     Document Type: Article

References (30)

1. Garland J., Buck R., Weinberg M. Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study. Pediatrics 1994, 94:719-723.
2. Gersony W.M., Peckham G.J., Ellison R.C., Miettinen O.S., Nadas A. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983, 102:895-906.
3. Grosfeld J.L., Chaet M., Molinari F., Engle W., Engum S.A., West K.W., et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg 1996, 224:350-355.
4. Macones G.A., Robinson C.A. Is there justification for using indomethacin in preterm labor? An analysis of neonatal risks and benefits. Am J Obstet Gynecol 1997, 177:819-824.
5. Panter K.R., Hannah M.E., Amankwah K.S., Ohlsson A., Jefferies A.L., Farine D. The effect of indomethacin tocolysis in preterm labour on perinatal outcome: a randomised placebo-controlled trial. Br J Obstet Gynaecol 1999, 106:467-473.
6. Zuckerman H., Shalev E., Gilad G., Katzuni E. Further study of the inhibition of premature labor by indomethacin. Part II double-blind study. J Perinat Med 1984, 12:25-29.
7. Loe S., Sanchez-Ramos L., Kaunitz A. Assessing the neonatal safety of indomethacin tocolysis. Obstet Gynecol 2005, 106:173-179.
8. Moise K.J., Ou C.N., Kirshon B., Cano L.E., Rognerud C., Carpenter R.J. Placental transfer of indomethacin in the human pregnancy. Am J Obstet Gynecol 1990, 162:549-554.
9. Moise K.J., Huhta J.C., Sharif D.S., Ou C.N., Kirshon B., Wasserstrum N., et al. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med 1988, 319:327-331.
10. Clyman R.I., Chen Y.Q., Chemtob S., Mauray F., Kohl T., Varma D.R., et al. In utero remodeling of the lamb ductus arteriosus: the role of AI and avascular zone thickness in vasa vasorum proliferation, neointima formation, and cell death. Circulation 2001, 103:1806-1812.
11. Cordero L., Nankervis C.A., Gardner D., Giannone P.J. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants. J Perinatol 2007, 27:22-27.
12. Hammerman C., Glaser J., Kaplan M., Schimmel M.S., Ferber B., Eidelman A.I. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics 1998, 102:1202-1232.
13. Norton M.E., Merrill J., Cooper B.A., Kuller J.A., Clyman R.I. Neonatal complications after the administration of indomethacin for preterm labor. New Eng J Med 1993, 329:1602-1607.
14. Souter D., Harding J., McCowan L., O'Donnell C., McLeay E., Baxendale H. AI-adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol 1998, 38:11-16.
15. Suarez V.R., Thompson L.L., Jain V., Olson G.L., Hankins G.D., Belfort M.A., et al. The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate. Am J Obstet Gynecol 2002, 187:886-888.
16. Takami T., Momma K., Imamura S. Increased constriction of the ductus arteriosus by dexamethasone, indomethacin, and rofecoxib in fetal rats. Circ J 2005, 69:354-358.
17. Shennan A.T., Dunn M.S., Ohlsson A., Lennox K., Hoskins E.M. Abnormal pulmonary outcomes in preterm infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988, 82:527-532.
18. Papile L.A., Munsick-Bruno G., Schaefer A. Relationship of cerebral intraventricular hemorrhage and early childhood handicaps. J Pediatr 1983, 103:272-277.
19. An international classification of retinopathy of prematurity. Pediatrics 1984, 74:127-133.
20. Clyman R.I., Campbell D., Heymann M.A., Mauray F. Persistent responsiveness of the neonatal ductus arteriosus in immature lambs: a possible cause for reopening of patent ductus arteriosus after indomethacin-induced closure. Circulation 1985, 71:141-145.
21. Momma K., Takao A. Increased constriction of the ductus arteriosus with combined administration of indomethacin and betamethasone in fetal rats. Pediatr Res 1989, 25:69-75.
22. Amin S.B., Sinkin R.A., Glantz J.C. Metaanalysis of the effect of AI on neonatal outcomes. Am J Obstet Gynecol 2007, 197(486):1-10.
23. Vermillion S., Newman R. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants. Am J Obstet Gynecol 1999, 181:1083-1086.
24. Chorne N., Jegatheesan P., Lin E., Shi R., Clyman R.I. Risk factors for persistent ductus arteriosus patency during indomethacin treatment. J Pediatr 2007, 151:629-634.
25. Clyman R.I., Chorne N. Patent ductus arteriosus: evidence for and against treatment. J Pediatr 2007, 150:216-219.
26. Kabra N.S., Schmidt B., Roberts R.S., Doyle L.W., Papile L., Fanaroff A. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007, 150:229-234.
27. Little D.C., Pratt T.C., Blalock S.E., Krauss D.R., Cooney D.R., Custer M.D. Patent ductus arteriosus in micropremie and full-term infants: the relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg 2003, 38:492-496.
28. Soraisham A.S., Lodha A.K., Al-Awad E., Sauve R. Surgical ligation of patent ductus arteriosus has an adverse impact on the neurodevelopmental outcome at 36 months in extremely low birth weight infants. Paediatr Child Health 2008, 13:19A.
29. Brock R.S., Beharry K.D., Coleman R.J., Aranda J.V., Modanlou H.D. Effects of early postnatal Ibuprofen and Indomethacin on ocular VEGF, soluble VEGF receptor-1, and IGF-I in a novel rat model for ROP. Paper presented at Pediatric Academic Societies' Annual Meeting; May 7, 2007 2007, 61:7165.7. E-PAS 61.
30. Jegatheesan P., Ianus V., Buchh B., Yoon G., Chorne N., Ewig A., et al. Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial. J Pediatr 2008, 153:183-189.